Breaking News

Gemini Bio Opens New cGMP Facility

Quadruples manufacturing capacity.

By: Contract Pharma

Contract Pharma Staff

Gemini Bioproducts LLC, a supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners LLC, a New York-based healthcare private equity firm, has announced the opening of a new manufacturing facility in West Sacramento, California.   Gemini Bio’s new facility was built to support the production of cell culture media, sera, buffers, and other reagents with products that serve the cell and gene therapy market. The newly constructed 25,000-square-foot cGMP facility with...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters